Affiliation:
1. Division of Infectious Diseases, Children's Hospital, Boston, Massachusetts.
Abstract
Routine monitoring of antibiotic resistance at Children's Hospital, Boston, detected a dramatic increase in the prevalence of imipenem-resistant strains of Pseudomonas aeruginosa. Further studies documented that false resistance to imipenem was due, in part, to the loss of imipenem potency in customized MIC microdilution trays supplied by Sensititre Ltd. (West Sussex, United Kingdom). Recognition of the problem was delayed by use of the quality control standard recommended by the manufacturer, which were higher and broader than those suggested by the National Committee for Clinical Laboratory Standards.
Publisher
American Society for Microbiology
Reference8 articles.
1. Bioactivity of imipenem as a function of medium, time, and temperature;Baron E. J.;Antimicrob. Agents Chemother.,1984
2. Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid;Barry A. L.;Diagn. Microbiol. Infect. Dis.,1987
3. Determination of imipenem (N-formimidoyl thienamycin) in human plasma and urine by high-performance liquid chromatography, comparison with microbiological methodology and stability;Gravallese D. A.;J. Chromatogr.,1984
4. National Committee for Clinical Laboratory Standards. 1984. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A3. National Committee for Clinical Laboratory Standards Villanova Pa.
5. National Committee for Clinical Laboratory Standards. 1985. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A. National Committee for Clinical Laboratory Standards Villanova Pa.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献